Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00220480
Status:
UNKNOWN
Last Update Posted:
2010-02-09
First Post:
2005-09-14
Brief Title:
A Naturalistic Study of the Efficacy and Safety of Escitalopram in Treatment Resistant Depression
Sponsor:
Sheba Medical Center
Organization:
Sheba Medical Center
Study Overview
Official Title:
None
Status:
UNKNOWN
Status Verified Date:
2010-02
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary objective of this multicenter study is to evaluate the efficacy of escitalopram in treatment resistant depression TRD assessed by 2 consecutive failed antidepressant treatments from different classes The last treatment received is a 6 week prospective trial with venlafaxine
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None